Rare Diseases and Orphan Products
Is payer scrutiny impacting access to your orphan drug?
Orphan Drugs: Five Ways to Prove Product Value
Even manufacturers of the most innovative treatments for rare diseases have to demonstrate value to a multitude of stakeholders. In this ebook, we explore how to prove product value in ways that matter most to payers, patients and providers. You'll learn: 1. Why creating a community for patients is critical. 2. How to educate and support physicians early. 3. Ways to overcome access barriers with evidence. 4. The importance of investing in patient support programs. 5. Channel strategy considerations for commercialization success. Get the insights you need to get your product to the patients who need it most.
Helping your most specialized populations – an Xcenda analysis
Start a conversation
We’re value drivers and problem solvers. Let us connect you with experts who understand your world and what success demands.